Proline metabolism in Leishmania tarentolae.
D000409:Alanine / Q000494:pharmacology; D000594:Amino Acid Oxidoreductases / Q000378:metabolism; D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D002952:Citric Acid Cycle; D003470:Culture Media / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology; D006909:Hydroxyproline / Q000494:pharmacology; D007891:Leishmania / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism*; D008291:Malate Dehydrogenase / Q000378:metabolism; D008715:Methionine / Q000494:pharmacology; D010101:Oxygen Consumption; D011392:Proline / Q000378:metabolism* / Q000494:pharmacology; D013053:Spectrophotometry
D000596:Amino Acids; D002247:Carbon Isotopes; D003470:Culture Media; D005971:Glutamates; D002245:Carbon Dioxide; D001224:Aspartic Acid; D011392:Proline; D008715:Methionine; D008291:Malate Dehydrogenase; D000594:Amino Acid Oxidoreductases; D005947:Glucose; D000409:Alanine; D006909:Hydroxyproline